SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Katharine Hepburn
| Patient | Katharine Hepburn |
|---|
| Date of birth | 1953-05-12 |
|---|
| Identifiers | MRN HR-ML012-SYN; SSN (made up) 000-12-8834 |
|---|
| Document date | 2026-01-13 |
|---|
| Author | Gwendolyn Price, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subjective
The patient attends this visit for tremor evaluation: head, voice, and hand tremor; tremor rating, reversible causes, and functional impact. [S]
Objective
Hemoglobin: 13.4 g/dL; Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.78 mg/dL; eGFR: 80 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.4 mg/dL; TSH: 2.2 mIU/L; PHQ-9: 2; MoCA: 28. [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-01-13 | Body height | 170 | cm | S |
| 2026-01-13 | Body weight | 56 | kg | S |
| 2026-01-13 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 2026-01-13 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-01-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-01-13 | Heart rate | 78 | /min | S |
| 2026-01-13 | Respiratory rate | 14 | /min | S |
| 2026-01-13 | Body temperature | 36.6 | Cel | S |
| 2026-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-01-13 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-01-13 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 80 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-13 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-13 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | | | S |
| 2026-01-13 | Total score [MoCA] | 28 | {score} | | | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Essential tremor: bilateral upper-limb action tremor with head (no-no) and voice tremor, without other neurological signs | active | provisional |
G25.0 | S — Synthetic modern coding of her publicly visible tremor; the label is a retrospective interpretation (R), so verification is provisional. Severity scores are synthetic. |
| Voice tremor due to essential tremor, mild, with a wavering pitch on sustained vowels | active | confirmed |
R49.8 | S — Synthetic modern coding anchored to public descriptions of her quivery voice; the severity at the index age is synthetic. |
Assessment
- Essential tremor: bilateral upper-limb action tremor with head (no-no) and voice tremor, without other neurological signs: active, provisional [S]
- Voice tremor due to essential tremor, mild, with a wavering pitch on sustained vowels: active, confirmed [S]
Plan of Treatment
- Movement disorders neurology consultation to confirm the diagnosis against the MDS consensus classification, choose treatment, and advise on head and voice tremor. Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018) [S]
- Monitor at every visit: TETRAS performance and daily-living subscales, spiral drawing and handwriting, heart rate and standing blood pressure on propranolol, side effects, falls, and drugs that worsen tremor; yearly: examination for signs beyond tremor, mood, cognition, and an AGS Beers Criteria medication review. Focused ultrasound thalamotomy or deep brain stimulation is considered only if disabling limb tremor persists after adequate trials of propranolol and primidone. Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor (2016); CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026) [S]
- Advance care planning: name a health care agent and record goals of care at the annual wellness visit. Guideline: CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026) [S]